Polymerase chain reaction (PCR) is used for accurate point of care diagnostics that help rapidly identify and determine the cause of respiratory tract infections. The growth of the PCR for respiratory infection diagnostics market is attributed to the factors such as the increasing Burden of Chronic Respiratory Diseases (CRDs), growing developments in PCR testing, are widely enhancing the performance of medical devices.
This report contains market size and forecasts of PCR For Respiratory Infection Diagnostic in Global, including the following market information:
Global PCR For Respiratory Infection Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global PCR For Respiratory Infection Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Reagents and Kits Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of PCR For Respiratory Infection Diagnostic include Abbott, F. Hoffmann-La Roche AG, Hologic, Inc., Seegene Inc., AusDiagnostics, BD, Bio-Rad Laboratories Inc, BioMerieux and Qiagen and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PCR For Respiratory Infection Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PCR For Respiratory Infection Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global PCR For Respiratory Infection Diagnostic Market Segment Percentages, by Type, 2021 (%)
Reagents and Kits
Instruments
Others
Global PCR For Respiratory Infection Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global PCR For Respiratory Infection Diagnostic Market Segment Percentages, by Application, 2021 (%)
Hospitals
Physician Clinics
Clinical Laboratories
Academic and Research Institutions
Biotech and Pharma Companies
Others
Global PCR For Respiratory Infection Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global PCR For Respiratory Infection Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies PCR For Respiratory Infection Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies PCR For Respiratory Infection Diagnostic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
F. Hoffmann-La Roche AG
Hologic, Inc.
Seegene Inc.
AusDiagnostics
BD
Bio-Rad Laboratories Inc
BioMerieux
Qiagen
Thermo Fisher Scientific Inc